Jonathan Tward

94 posts

Jonathan Tward

Jonathan Tward

@prostatemd

Cancer Physician/Scientist Leader, Huntsman Cancer Institute Genitourinary Cancers Center Professor of Radiation Oncology

Salt Lake City, UT Beigetreten Kasım 2011
172 Folgt376 Follower
Jonathan Tward retweetet
Daniel E Spratt
Daniel E Spratt@DrSpratticus·
X-torial: Cleaning up the misinformation about @JoeBiden and #ProstateCancer that I am reading everywhere. The purpose of this is to provide education from someone who treats and studies PCa for a living, lead the USA @NCCN PCa guidelines, hold leadership in @NRGonc @theNCI @US_FDA and dedicated my career to help men and their families suffering from PCa @nytimes @WSJ @FoxNews @CNN @NBCNews @Reuters @ASCO @PCFnews @DeptofDefense
English
26
147
366
85.2K
Steven Seyedin
Steven Seyedin@snseyedinMD·
At @ASCO in Chicago and looking for fellow GU radoncs to meet. Anyone around?
English
2
1
11
631
Jonathan Tward
Jonathan Tward@prostatemd·
@BioprotectS @huntsmancancer @Huntsman_GU This is a very impressive perirectal spacer. I have done a bunch of cases now. Perfect space every time so far, adaptable, and moveable. Very easy to apply. An outstanding tool in a category with several good options
English
1
0
1
40
Daniel E Spratt
Daniel E Spratt@DrSpratticus·
An incredible honor to go through this special white coat ceremony to receive the @UHhospitals Distinguished Professor honor alongside multiple inspirational physicians who give phenomenal care to patients. Thank you @DanSimonMD and the whole UH leadership, and of course everyone in @RadOncUH who really gets the credit for the amazing care our patients receive. 🙏🙏🙏
Daniel E Spratt tweet media
Nicholas Zaorsky, MD MS@NicholasZaorsky

Kudos to @DrSpratticus for being recognized as a distinguished physician, typically an honor reserved for senior docs, and given to Dan just 2 years in leading @UHhospitals #RadOnc @RadOncUH department. @ASTRO_org @ESTRO_RT @ACRORadOnc @ARRO_org

Shaker Heights, OH 🇺🇸 English
8
2
119
18.7K
Jonathan Tward retweetet
Daniel E Spratt
Daniel E Spratt@DrSpratticus·
Tweetorial on our recently published paper in @NEJMEvidence on the development and validation of the 1st predictive biomarker to guide ADT use in prostate cancer. Enjoy! #PCSM @arteraAI @NRGonc @felixfengmd @DrHowardSandler @EdwardSchaeffer @prostatemd @AarmstrongDuke
Daniel E Spratt@DrSpratticus

One of the most impactful projects I have been fortunate to be part of with many incredible collaborators, @felixfengmd , @NRGonc , @arteraAI all coming together to create the 1st validated predictive biomarker for ADT use in PCa. Big win for patients! @uhradonc @caseccc #PCSM

English
9
48
162
73.8K
Neeraj Agarwal, MD, FASCO
Neeraj Agarwal, MD, FASCO@neerajaiims·
Breaking news👉@US_FDA approves Talazoparib + Enzalutamide for mCRPC #prostatecancer with HRR mutations. Weblink👉 tinyurl.com/bdhabbkt Efficacy data, HRR mutations👇@PCFnews @OncoAlert @urotoday @huntsmancancer Gratifying to see the success of this trial we started 6 yrs ago
Neeraj Agarwal, MD, FASCO tweet mediaNeeraj Agarwal, MD, FASCO tweet mediaNeeraj Agarwal, MD, FASCO tweet mediaNeeraj Agarwal, MD, FASCO tweet media
Neeraj Agarwal, MD, FASCO@neerajaiims

We report in @TheLancet : Primary efficacy data from TALAPRO-2 Phase 3 trial in mCRPC #prostatecancer : Talazoparib + Enza improves outcomes in all subgroups vs Enza. Prospective tissue testing in 100% pts, randomization stratified by HRR status @oncoalert @urotoday @PCF_Science

English
11
93
270
178.6K
Jonathan Tward retweetet
Neeraj Agarwal, MD, FASCO
Neeraj Agarwal, MD, FASCO@neerajaiims·
#ASCO23 @asco PEACE-1 trial by Dr. Bossi👉Significant delay in disease progression and delay of serious GU obstructive events by radiation therapy in mCSPC (no OS benefit): results confirm the role of radiation in low volume denovo mCSPC @OncoAlert @urotoday @PCFnews
Neeraj Agarwal, MD, FASCO tweet mediaNeeraj Agarwal, MD, FASCO tweet mediaNeeraj Agarwal, MD, FASCO tweet mediaNeeraj Agarwal, MD, FASCO tweet media
English
4
91
175
39.9K
Jonathan Tward retweetet
GU Cancer Research Program @HuntsmanCancer
GU Cancer Research Program @HuntsmanCancer@Huntsman_GU·
Join us for the #HuntsmanSportsFest to help raise money for #prostatecancer research at HCI #ReasonToHope We can end cancer — together. Will you make a donation to help support our fundraising goal today? Weblink👉 rb.gy/819hr @huntsmancancer @BogdanaSchmidt @ASanchez_UroOnc @prostatemd @sky__john @NeliMUlrich @helops79 @neerajaiims @nsayeghmd @umangtalking @maughanonc @vinay_onc
Neeraj Agarwal, MD, FASCO@neerajaiims

Join us for the #HuntsmanSportsFest to help raise money for #prostatecancer research at HCI #ReasonToHope We can end cancer — together. Will you make a donation to help support our fundraising goal today? Weblink👉 rb.gy/819hr @huntsmancancer @Huntsman_GU @sky__john @prostatemd

English
0
4
4
1.1K
Jonathan Tward
Jonathan Tward@prostatemd·
Alas! My medical scribes always get into medical school and leave me 😉. If you know a smart college grad who would like to work as my scribe/research assistant for at least 1 year @huntsmancancer . Please encourage them to apply: tinyurl.com/y58yy9sj
English
1
1
4
377
Daniel E Spratt
Daniel E Spratt@DrSpratticus·
Great data to discuss with patients. Builds on ProtecT. Great contemporary data on just 5 fx of RT vs radical prostatectomy. Especially now given RCT data for spacers and/or MRIdian (ie MIRAGE). MAJOR kudos to trial team and pts for pulling this off! @PCFnews @urotoday
Neeraj Agarwal, MD, FASCO@neerajaiims

Abs#298 @ASCO #GU23 👉bit.ly/3E4TrX0: In pts with localized #prostatecancer (T1-T2; Gleason ≤ 3 + 4; PSA ≤ 20 ng/mL) ➡️ radiation (SBRT) associated with better urinary continence & sexual bother but more bowel bother after 2 yrs vs surgery @urotoday @PCFnews @Uromigos

English
5
26
80
35.1K

Entdecken

@JoeBiden @NCCN @NRGonc @theNCI @US_FDA @nytimes @WSJ @FoxNews